Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus

Journal of Orthopaedic Research

Volumn 28, Issue 7, 2010, Pages 942-949

  Breitbart, Eric A ^a   Meade, Sharonda ^a   Azad, Vikrant ^a   Yeh, Sloane ^a   Al Zube, Loay ^a,b,c   Lee, Yee Shuan ^b   Benevenia, Joseph ^a   Arinzeh, Treena Livingston ^b   Lin, Sheldon S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^c HASHEMITE UNIVERSITY   (Jordan)

Author keywords

Allograft; Bone; Diabetes; Healing; Mesenchymal stem cell

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ALLOGRAFT; BONE MATRIX; BONE REGENERATION; CONTROLLED STUDY; DIABETES MELLITUS; HISTOLOGY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALS; BONE DEMINERALIZATION TECHNIQUE; BONE TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FRACTURE HEALING; FRACTURES, BONE; GRAFT SURVIVAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOTOMY; RATS; RATS, INBRED BB; TRANSPLANTATION, HOMOLOGOUS;

EID: 77953193003     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21065     Document Type: Article

References (55)

1. Langer R, Vacanti JP. 1993. Tissue engineering. Science 260: 920-926.
2. Praemer A, Furner S, Rice D. 1999. Musculoskeletal conditions in the United States. Rosemont, IL: American Academy of Orthopedic Surgeons.
3. Yaszemski MJ, Payne RG, Hayes WC, et al. 1996. Evolution of bone transplantation. Molecular, cellular, and tissue strategies to engineer human bone. Biomaterials 17:175-185.
4. Arinzeh TL, Peter SJ, Archambault MP, et al. 2003. Allogenic mesenchymal stem cells regerate bone in a critical-sized canine segmental defect. J Bone Joint Surg 85-A:1927-1935.
5. Gazdag AR, Lane JM, Glaser D, et al. 1995. Alternatives to autogenous bone graft: efficacy and idications. J Am Acad Orthop Surg 3:1-8.
6. Damien C, Parsons JR. 1991. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2:187-208.
7. Laurie SW, Kaban LB, Mulliken JB, et al. 1984. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 73:933-938.
8. Younger EM, Chapman MW. 1989. Morbidity at bone graft donor sites. J Orthop Trauma 3:192-195.
9. Mankin HJ. 2003. The changes in major limb reconstruction as a result of the development of allografts. Chir Organi Mov 88:101-113.
10. Hollinger JO, Brekke J, Gruskin E, et al. 1996. Role of bone substitutes. Clin Orthop 324:55-65.
11. Johnson KD, Frierson KE, Keller TS, et al. 1996. Porous ceramics as bone graft substitutes in long bone defects: a biomechanical, histological and radiographic analysis. J Orthop Res 14:351-369.
12. Zardiackas LD, Teasdall RD, Black RJ, et al. 1994. Torsional properties of healed canine diaphyseal defects grafted with a fibrillar collagen and hydroxyapatite/tricalcium phosphate composite. J Appl Biomater 5:277-283.
13. Bruder SP, Kraus KH, Goldberg VM, et al. 1998. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg 80-A:985-996.
14. Stevenson S, Cunningham N, Toth T, et al. 1994. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in ortotopic segmental defects in rats. J Bone Joint Surg 76-A:1676-1687.
15. Bruder SP, Caplan AI. 1990. Terminal differentiation of osteogenic cells in the embryonic tibia is revealed by a monoclonal antibody against osteocytes. Bone 11:189-198.
16. Goshima J, Goldberg VM, Caplan AI. 1991. The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks. Clin Orthop Rel Res 262:298-311.
17. Haynesworth SE, Gishima J, Goldberg VM, et al. 1992. Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
18. Mardon HF, Bee J, Mark VD, et al. 1987. Development of osteogenic tissue in diffusion chambers from early precursor cells in bone marrow of adult rats. Cell Tissue Res 250:157-165.
19. Ohgishi H, Goldberg VM, Caplan AI. 1989. Heterotopic osteogenesis in porous ceramics, induced by marrow cells. J Orthop Res 7: 568-578.
20. Owens ME, Friedenstein AJ, Evered D, Harnett S. 1988. Stromal stem cells: marrow-derived osteogenic precursors. In: Evered D, Harnett S, editor. Cell and molecular biology of vertebrate hard tissues. New York: Wiley. p 42-60.
21. Masuda T, Yliheikkilä PK, Felton DA, et al. 1998. Generalizations regarding the process and phenomenon of osseointegration. Part I. In vivo studies. Int J Oral Maxillofac Implants 13: 17-29. (Pubitemid 128505822)
22. Cozen L. 1972. Does diabetes delay fracture healing? Clin Orthop 82:134-140.
23. Loder RT. 1988. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop 232:210-216.
24. Caplan AI, Bruder SP. 2001. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264.
25. Khan SN, Cammisa FP, Sandhu HS, et al. 2005. The biology of bone grafting. J Am Acad Orthop Surg 13:77-86.
26. Kraus KH, Kirker-Head C. 2006. Mesenchymal stem cells and bone regeneration. Vet Surg 35:232-242.
27. Al-Zube L, Breitbart EA, O'Connor JP. 2009. Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res.
28. Azad V, Breitbart EA, Al-Zube LA, et al. 2009. rhBMP-2 enhances the bone healing response in a diabetic rat segmental defect model. J Orthop Trauma 23:267-276.
29. DePaula CA, Truncale CA, Getzman AA, et al. 2005. Effects of hydrogen peroxide cleaning procedures on bone graft osteoinductivity and mechanical properties. Cell Tissue Bank 6:287-298.
30. Livingston T, Ducheyne P, Garino J. 2002. An in vivo evaluation of a bioactive ceramic scaffold for bone tissue engineering. J Biomed Mater Res 62: 1-13.
31. Maniatopoulos C, Sodek J, Melcher AH. 1988. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254: 317-330.
32. Jaiswal N, Haynesworth SE, Caplan AI, et al. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
33. Kadiyala S, Young RG, Thiede MA, Bruder SP. 1997. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6: 125-134.
34. Rickard DJ, Sullivan TA, Shenker BJ, et al. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228.
35. Livingston-Arinzeh T, Peter SJ, Archambault MP, et al. 2003. Allogenic mesenchymal stem cell regenerate bone in a criticalsized canine segmental defect. J Bone Joint Surg 85-A: 1927-1935.
36. Einhorn TA, Lane JM, Burstein AH, et al. 1984. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am 66: 274-279.
37. Nottebaert M, Lane JM, Juhn A, et al. Omental angiogenic lipid fraction and bone repair. An experimental study in the rat. J Orthop Res 7: 157-169.
38. Page K, Stevens A, Lowe J, et al. 1996. In: Stevens JB, Bancroft JD, editors. Theory and practice of histological techniques. New York: Churchill Livingstone Inc.
39. Harten RD, Svach DJ, Schmelzer R, et al. 2005. Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo. J Biomed Mater Res A 72: 354-362.
40. Seeherman HJ, Azari K, Bidic S, et al. 2006. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Joint Surg Am 88: 1553-1565.
41. Beam HA, Parsons JR, Lin SS. 2002. The effects of blood glucose control upon fracture healing in the BB Wistar rats with diabetes mellitus. J Orthop Res 20: 1210-1216.
42. Funk JR, Hale JE, Carmines D, et al. 2000. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res 18: 126-132.
43. Topping RE, Bolander ME, Balian G. 1994. Type X collagen in fracture callus and the effects of experimental diabetes. Clin Orthop Relat Res 308: 220-228.
44. Balint E, Szabo P, Marshall CF, et al. 2001. Glucose-induced inhibition of in vitro bone mineralization. Bone 28: 21-28.
45. Reiser KM. 1991. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 196: 17-29.
46. Santana RB, Xu L, Babakhanlou Chase H, et al. 2003. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52: 1502-1510.
47. Terada M, Inaba M, Yano Y, et al. 1998. Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 22: 17-23.
48. Zhang X, Xie C, Lin ASP, et al. 2005. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20: 2124-2137.
49. Block JE. 2005. The role and effectiveness of bone marrow in osseous regeneration. Med Hypotheses 65: 740-757.
50. Dumas A, Moreau MF, Ghérardi RK, et al. 2009. Bone grafts cultured with bone marrow stromal cells for the repair of critical bone defects: an experimental study in mice. J Biomed Mater Res A 90: 1218-1229.
51. Hernigou P, Poignard A, Beaujeau F, et al. 2005. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87: 1430-1437.
52. Balcik C, Tokdemir T, Senköyfüuml A, et al. 2007. Early weight bearing of porous HA/TCP (60/40) ceramics in vivo: a longitudinal study in a segmental bone defect model of rabbit. Acta Biomater 3: 985-996.
53. Kawcak CE, Trotter GW, Powers BE, et al. 2000. Comparison of bone healing by demineralized bone matrix and autogenous cancellous bone in horses. Vet Surg 29: 218-226.
54. Manjubala I, Sastry TP, Kumar RV. 2005. one in-growth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl 19: 341-360.
55. Wingerter S, Tucci M, Bumgardner J, et al. 2007. Evaluation of short-term healing following sustained delivery of osteoinductive agents in a rat femur drill defect model. Biomed Sci Instrum 43: 188-193.